CARsgen Therapeutics, a clinical-stage company developing Chimeric Antigen Receptor T cell therapies for cancer, has appointed Yong Fan, MD, as senior vice president, Global Regulatory Affairs. Dr. Fan will be responsible for CARsgen global regulatory strategy, leading the U.S. and China regulatory affairs team and working with clinical, medical and process development teams to advance CARsgen’s strategic objectives for immunotherapies. Dr. Fan previously served as A2Z Reg Solutions senior co...